An overview on solid tumor biomarker and treatment landscape

Nicola Normanno, MD
Director of the Cell Biology and Biotherapy Unit and Translational Research Department, National Cancer Institute—Fondazione G. Pascale, Naples, Italy

Introducing the new NGS solution for routine oncology biomarker testing everywhere

Luca Quagliata, PhD, BCMAS
Vice President and Global Head of Medical Affairs, Thermo Fisher Scientific

Removing barriers to enable routine NGS testing–results of multicentric evaluation of performance of the Oncomine Dx Express Test

Paul Hofman, MD, PhD
Professor of Pathology, Laboratory of Clinical and Experimental Pathology at Louis Pasteur Hospital, Nice, France

Clinical Cases Debate

 

Nicola Normanno, MD
Paul Hofman, MD, PhD

 

 

You May Also Like

Ready To Learn More?

Ask our NGS experts any questions or subscribe to get helpful updates from our team, including whitepapers, webinars, videos, case studies and more!